March 28, 2017
Therigy is featured in a Specialty Pharmacy Continuum article discussing how a growing number of integrated delivery networks (IDNs) are establishing their own internal specialty pharmacies to contain drug costs, maintain better control over their patients' care and outcomes, and capture some of the lucrative specialty market.
Some highlights of the article include:
"Although coming somewhat later to the specialty game than stand-alone specialty pharmacies and large national chains, hospital and health system based-IDNs have a few built-in advantages. One of the biggest of these is their ability to leverage the kind of specialty data that both pharmaceutical manufacturers and third-party payors are looking for."
"Russ Allinson, RPh, MS, the CEO and Chief Clinical Officer of the specialty solutions company Therigy, agreed that IDNs have unique areas giving them a jump-start when it comes to specialty data. This is primarily due, he said, to their control of and comprehensive access to the electronic health record (EHR), regular face-to-face interaction with the integrated health care team, and regular face-to-face interaction with patients. The EHR gives the IDN the opportunity to access all sorts of data about the patient that even the best stand-alone specialty pharmacy does not have access to. Because the IDN specialty pharmacist typically works in clinic with the other health care providers ranging from physicians and nurses to dietitians and social workers, they have insights to patients' conditions that they would not otherwise have. And finally, because they are often co-located or adjacent to clinics where patients come in for updates, specialty pharmacists in IDNs see their patients face to face a fair percentage of the time, which offers more information than purely telephonic, text or mail interaction."
"...the future is going to be in the data, manufacturers and payors want outcomes, Dr. Newman said."
To read the entire article, please click here.